Navigation Links
Updated Phase 2 Data With Flutemetamol Published in Annals of Neurology
Date:9/8/2010

PRINCETON, N.J., Sept. 7 /PRNewswire/ -- GE Healthcare announced today that results from its multicenter phase 2 study of flutemetamol were published in the September issue of Annals of Neurology. Flutemetamol is an investigational positron emission tomography (PET) imaging agent being developed by GE Healthcare, in the field of brain imaging.

The purpose of the phase 2 study was to investigate the efficacy of flutemetamol in differentiating between patients with clinically probable Alzheimer's disease (AD) and cognitively intact healthy volunteers (HVs). The primary endpoint was the efficacy of blinded assessments of flutemetamol binding to Beta-amyloid, the major constituent of amyloid plaque, which is a pathological hallmark of AD. In the study, subjects with a high probability of amyloid (27 AD patients) and a low probability of amyloid (25 healthy subjects) underwent PET imaging with flutemetamol. Five independent image readers, each blinded to the subject's clinical status, separately decided if each subject's image corresponded to normal or raised amyloid levels. The accuracy of image assessments was determined by comparing them to the subjects' clinical diagnoses. In addition, 20 subjects with a memory disorder known as mild cognitive impairment (MCI), which may represent a pre-dementia stage of AD, were enrolled and imaged with flutemetamol.

The image readers found that scans from 25 of the 27 AD patients displayed elevated flutemetamol uptake, as did 1 of 15 HVs who were older than 55 years, corresponding to a sensitivity of 93.1% and a specificity of 93.3% against their clinical diagnoses. In the group with MCI, visual inspection revealed raised binding of flutemetamol in 9 of 20 subjects. Test-retest reliability was very high when subjects underwent repeat scanning after 7 days. Additionally, comparable uptake ratios were seen when compared to 11CPIB of which flutemetamol is an analog.

"These data show that flutemetamol ex
'/>"/>

SOURCE GE Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
6. IDM Pharma Announces IDM-2101 Updated Phase 2 Results Show Treatment Well Tolerated With Positive Survival Trend in Lung Cancer Patients
7. IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
8. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
9. ORTHO EVRA(R) Prescribing Information Updated
10. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
11. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... DIEGO , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... and development of drugs targeting unmet needs in oncology, autoimmune ... Baird 2014 Health Care Conference to be held at The ... on September 3-4, 2014. Alan ... Company and its lead drug candidate, quizartinib, at 1:10 p.m. ...
(Date:8/27/2014)... 27, 2014  After the February 2014 launch of ... solution for medical practices and management companies, Prime ... new software. "The feedback has been great," ... "The sheer number of demos and new sign-ups is ... for these types of software features." ...
(Date:8/27/2014)... 27, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be participating in the Morgan Stanley 2014 ... New York, New York , on Tuesday, ... CEO of Zimmer, will be presenting at 9:10 a.m. ... of Biomet, will join Mr. Dvorak for the Q&A ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
... 9, 2012 Young Innovations, Inc. (NASDAQ – YDNT) ... quarterly dividend of $0.04 per share, payable June 15, ... 2012. Young Innovations develops, manufactures and markets ... assistants and consumers. The Company,s consumables product offering includes ...
... for WAISMANN METHOD® rapid opiate detox treatment ... support for National Fibromyalgia Awareness Day, taking place on ... are being prescribed opiate painkillers to address their chronic ... prescription painkiller use is also surging nationwide.  ...
Cached Medicine Technology:Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend 2WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day 2
(Date:8/27/2014)... Lee Antimicrobial Solutions LLC (“LAMS”), the ... and a Leader in Environmental Disinfection Device Design, ... device developed for home use available for the ... DHP Technology, a revolutionary means to disinfect your ... bacteria, viruses, microbes and offensive odors. A technology ...
(Date:8/27/2014)... York (PRWEB) August 27, 2014 Power ... in U.S. courts on behalf of women who allegedly ... morcellation, Bernstein Liebhard LLP reports. According to court documents, ... August 18th in the U.S. District Court, Northern District ... who claims the use of a power morcellator manufactured ...
(Date:8/27/2014)... 2014 Picture, if you will, a detective ... but more of a Mr. Inside, a Doc Blanchard type, ... personalities and world view. This Mr. Inside was an internationally ... Austin, and Mr. Outside was an Austin Police Department lieutenant. ... girlfriend, and a gaggle of teenagers embarked on a mission ...
(Date:8/27/2014)... When Jagger was 20 years old and at ... that he credits as one of the most memorable phone ... she could set him up with a summer job; one ... that job, and he has now spent the past 22 ... he also worked in school boards, employment programs and youth ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The newest ... PA on Monday, September 8, 2014. This new 15,000 ... that features three primary care practices and walk-in laboratory ... is a very exciting endeavor for Abington Health as ... and CEO, Abington Health. “Establishing a location in Lower ...
Breaking Medicine News(10 mins):Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 2Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Abington Health Opens New Health Center in Lower Gwynedd 2
... WASHINGTON, DC -- A study in the December issue of ... as to why death rates for less educated middle aged ... despite increased awareness and treatments aimed at reducing health disparities. ... with low education levelsthat is high school or lessare twice ...
... HealthDay Reporter , WEDNESDAY, Dec. 14 (HealthDay News) -- Every ... rape, physical violence, or stalking by an intimate partner, according ... to data from the U.S. Centers for Disease Control and ... of partner violence each year, with by far the biggest ...
... 14 (HealthDay News) -- ,Headache affects 50 percent of HIV/AIDS ... are severe, a new study says. About 27.5 percent ... migraine," a rare condition in which a person has migraine ... days a month. This condition occurs in only 2 percent ...
... will have been diagnosed with locally-advanced pancreatic cancer in ... treatment option for these patients whose tumor has grown ... the past 20 years, numerous treatment regimens have been ... by chemoradiation being the current standard approach. However, the ...
... countries rely on traditional medicine as an accessible and ... scientific data has not existed to evaluate the potential ... the William L. Brown Center of the Missouri Botanical ... shrimp to determine the toxicity of 341 Northern Peruvian ...
... HealthDay Reporter , WEDNESDAY, Dec. 14 (HealthDay News) ... from sensing or reacting to anything happening to their ... recognizing a person sitting to that side -- may recover ... brain, Italian researchers report. This inability to process and ...
Cached Medicine News:Health News:Study takes aim at education-based death rate disparities 2Health News:Millions of Americans Are Victims of Sexual Violence: CDC 2Health News:Millions of Americans Are Victims of Sexual Violence: CDC 3Health News:Headaches May Plague Many With HIV/AIDS 2Health News:RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer 2Health News:Missouri Botanical Garden scientists examine toxicity of medicinal plants in Peru 2Health News:Missouri Botanical Garden scientists examine toxicity of medicinal plants in Peru 3Health News:Magnetic Brain Stimulation Might Help Some Stroke Patients 2Health News:Magnetic Brain Stimulation Might Help Some Stroke Patients 3
... is the First and Only ... the powerful technology of RESTORE with ... to create the unrivaled RESTOREPRIME. The ... and coverage for managing patients with ...
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....
... Atlas II HF systems are intended to ... for automated treatment of life-threatening ventricular arrhythmias. ... Atlas II HF systems are also intended:, ... symptoms of moderate to severe heart failure ...
Medicine Products: